# Evaluation of Coronary Luminal Diameter Enlargement With Emerge™ 1.20 mm PTCA Dilatation Catheter

> **NCT01635881** · PHASE3 · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 60 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Emerge™ 1.20 mm PTCA Dilatation Catheter

## Key facts

- **NCT ID:** NCT01635881
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2013-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01635881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01635881, "Evaluation of Coronary Luminal Diameter Enlargement With Emerge™ 1.20 mm PTCA Dilatation Catheter". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT01635881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*